Probably but not what people might think. More around internal clean up of the company, clear path to financial stability , continue to establish LL among the healthcare community , strategic plan for go forward actions such as what the focus will be for Leronlimab and what won’t ( this one is completed.

Those would be my assumptions around what he will be measured on to get promoted